Verition Fund Management LLC Agenus Inc Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.35 - $3.47 $1.42 Million - $2.1 Million	-605,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $1.77 Million - $3.47 Million	605,000 New	605,000 $1.95 Million
Q3 2021 Nov 15, 2021	SELL	$4.98 - $6.63 $190,818 - $254,041	-38,317 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $14,743 - $31,616	5,759 Added 17.69%	38,317 $210,000
Q1 2021 May 18, 2021	SELL	$2.69 - $5.25 $482,039 - $940,784	-179,197 Reduced 84.62%	32,558 $88,000
Q4 2020 Feb 16, 2021	SELL	$3.17 - $4.49 $223,294 - $316,275	-70,440 Reduced 24.96%	211,755 $673,000
Q3 2020 Nov 16, 2020	BUY	$2.98 - $5.2 $840,941 - $1.47 Million	282,195 New	282,195 $1.13 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.